Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis

Conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr−/− mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicke...

Full description

Bibliographic Details
Main Authors: Arnab Chattopadhyay, Pallavi Mukherjee, Dawoud Sulaiman, Huan Wang, Victor Girjalva, Nasrin Dorreh, Jonathan P. Jacobs, Samuel Delk, Wouter H. Moolenaar, Mohamad Navab, Srinivasa T. Reddy, Alan M. Fogelman
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227523000433
_version_ 1797822143004672000
author Arnab Chattopadhyay
Pallavi Mukherjee
Dawoud Sulaiman
Huan Wang
Victor Girjalva
Nasrin Dorreh
Jonathan P. Jacobs
Samuel Delk
Wouter H. Moolenaar
Mohamad Navab
Srinivasa T. Reddy
Alan M. Fogelman
author_facet Arnab Chattopadhyay
Pallavi Mukherjee
Dawoud Sulaiman
Huan Wang
Victor Girjalva
Nasrin Dorreh
Jonathan P. Jacobs
Samuel Delk
Wouter H. Moolenaar
Mohamad Navab
Srinivasa T. Reddy
Alan M. Fogelman
author_sort Arnab Chattopadhyay
collection DOAJ
description Conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr−/− mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicked the dyslipidemia and atherosclerosis induced by feeding a Western diet (WD). Here, we report that adding unsaturated LPA to standard mouse chow also increased the content of reactive oxygen species and oxidized phospholipids (OxPLs) in jejunum mucus. To determine the role of intestinal autotaxin, enterocyte-specific Ldlr−/−/Enpp2 KO (intestinal KO) mice were generated. In control mice, the WD increased enterocyte Enpp2 expression and raised autotaxin levels. Ex vivo, addition of OxPL to jejunum from Ldlr−/− mice on a chow diet induced expression of Enpp2. In control mice, the WD raised OxPL levels in jejunum mucus and decreased gene expression in enterocytes for a number of peptides and proteins that affect antimicrobial activity. On the WD, the control mice developed elevated levels of lipopolysaccharide in jejunum mucus and plasma, with increased dyslipidemia and increased atherosclerosis. All these changes were reduced in the intestinal KO mice. We conclude that the WD increases the formation of intestinal OxPL, which i) induce enterocyte Enpp2 and autotaxin resulting in higher enterocyte LPA levels; that ii) contribute to the formation of reactive oxygen species that help to maintain the high OxPL levels; iii) decrease intestinal antimicrobial activity; and iv) raise plasma lipopolysaccharide levels that promote systemic inflammation and enhance atherosclerosis.
first_indexed 2024-03-13T10:03:33Z
format Article
id doaj.art-c456bf32fd6f45f5a462ebc2070084da
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-03-13T10:03:33Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-c456bf32fd6f45f5a462ebc2070084da2023-05-23T04:20:37ZengElsevierJournal of Lipid Research0022-22752023-05-01645100370Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosisArnab Chattopadhyay0Pallavi Mukherjee1Dawoud Sulaiman2Huan Wang3Victor Girjalva4Nasrin Dorreh5Jonathan P. Jacobs6Samuel Delk7Wouter H. Moolenaar8Mohamad Navab9Srinivasa T. Reddy10Alan M. Fogelman11Division of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USAThe Vatche and Tamar Manoukian Division of Digestive Diseases, Fielding School of Public Health, University of California, Los Angeles, CA, USA; UCLA Microbiome Center, Fielding School of Public Health, University of California, Los Angeles, CA, USA; David Geffen School of Medicine at UCLA and the Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Administration Greater Los Angeles Healthcare System Los Angeles, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USA; Molecular Toxicology Interdepartmental Degree Program, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Biochemistry, Netherlands Cancer Institute, Amsterdam, the NetherlandsDivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USADivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USA; Molecular Toxicology Interdepartmental Degree Program, Fielding School of Public Health, University of California, Los Angeles, CA, USA; Department of Molecular and Medical Pharmacology, Fielding School of Public Health, University of California, Los Angeles, CA, USA; For correspondence: Srinivasa T. ReddyDivision of Cardiology, Department of Medicine, Fielding School of Public Health, University of California, Los Angeles, CA, USAConversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr−/− mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicked the dyslipidemia and atherosclerosis induced by feeding a Western diet (WD). Here, we report that adding unsaturated LPA to standard mouse chow also increased the content of reactive oxygen species and oxidized phospholipids (OxPLs) in jejunum mucus. To determine the role of intestinal autotaxin, enterocyte-specific Ldlr−/−/Enpp2 KO (intestinal KO) mice were generated. In control mice, the WD increased enterocyte Enpp2 expression and raised autotaxin levels. Ex vivo, addition of OxPL to jejunum from Ldlr−/− mice on a chow diet induced expression of Enpp2. In control mice, the WD raised OxPL levels in jejunum mucus and decreased gene expression in enterocytes for a number of peptides and proteins that affect antimicrobial activity. On the WD, the control mice developed elevated levels of lipopolysaccharide in jejunum mucus and plasma, with increased dyslipidemia and increased atherosclerosis. All these changes were reduced in the intestinal KO mice. We conclude that the WD increases the formation of intestinal OxPL, which i) induce enterocyte Enpp2 and autotaxin resulting in higher enterocyte LPA levels; that ii) contribute to the formation of reactive oxygen species that help to maintain the high OxPL levels; iii) decrease intestinal antimicrobial activity; and iv) raise plasma lipopolysaccharide levels that promote systemic inflammation and enhance atherosclerosis.http://www.sciencedirect.com/science/article/pii/S0022227523000433lysophospholipase Dlysophosphatidic acidatherosclerosisoxidized phospholipidssmall intestineapolipoprotein A-I mimetic peptides
spellingShingle Arnab Chattopadhyay
Pallavi Mukherjee
Dawoud Sulaiman
Huan Wang
Victor Girjalva
Nasrin Dorreh
Jonathan P. Jacobs
Samuel Delk
Wouter H. Moolenaar
Mohamad Navab
Srinivasa T. Reddy
Alan M. Fogelman
Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
Journal of Lipid Research
lysophospholipase D
lysophosphatidic acid
atherosclerosis
oxidized phospholipids
small intestine
apolipoprotein A-I mimetic peptides
title Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
title_full Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
title_fullStr Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
title_full_unstemmed Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
title_short Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis
title_sort role of enterocyte enpp2 and autotaxin in regulating lipopolysaccharide levels systemic inflammation and atherosclerosis
topic lysophospholipase D
lysophosphatidic acid
atherosclerosis
oxidized phospholipids
small intestine
apolipoprotein A-I mimetic peptides
url http://www.sciencedirect.com/science/article/pii/S0022227523000433
work_keys_str_mv AT arnabchattopadhyay roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT pallavimukherjee roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT dawoudsulaiman roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT huanwang roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT victorgirjalva roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT nasrindorreh roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT jonathanpjacobs roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT samueldelk roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT wouterhmoolenaar roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT mohamadnavab roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT srinivasatreddy roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis
AT alanmfogelman roleofenterocyteenpp2andautotaxininregulatinglipopolysaccharidelevelssystemicinflammationandatherosclerosis